| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2873603 | The Annals of Thoracic Surgery | 2013 | 6 Pages |
Abstract
The effect of VPI on survival in NSCLC varies greatly with tumor size, with VPI not strongly associated with OS or DFS in tumors smaller than 5 cm, but showing large negative effects on DFS for stage T2b and stage T3 tumors. Using VPI to upstage T1 tumors to a higher T stage is not warranted because it would misrepresent these VPI-T stage subgroup effects.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Elizabeth MD, Peter F. PhD, Neda MD, Wayne L. MD, David C. MD, Jack A. MD, Stephen G. MD, Garrett L. MD, Ara A. MD, Caimea PhD, Reza J. MD,